83 results on '"Kawashima, Ikuo"'
Search Results
2. Phosphacan acts as a repulsive cue in murine and rat cerebellar granule cells in a TAG‐1/GD3 rafts‐dependent manner
3. PKCδ deficiency inhibits fetal development and is associated with heart elastic fiber hyperplasia and lung inflammation in adult PKCδ knockout mice
4. Cover Feature: Systematic Study on the Catalytic Arsa‐Wittig Reaction (Chem. Eur. J. 59/2020)
5. Systematic Study on the Catalytic Arsa‐Wittig Reaction
6. Dibenzoarsepins: Planarization of 8π‐Electron System in the Lowest Singlet Excited State
7. Dibenzoarsepins: Planarization of 8π‐Electron System in the Lowest Singlet Excited State
8. Peraryl Arsoles: Practical Synthesis, Electronic Structures, and Solid-State Emission Behaviors
9. Cover Feature: Peraryl Arsoles: Practical Synthesis, Electronic Structures, and Solid-State Emission Behaviors (Chem. Eur. J. 35/2018)
10. Multi-mode emission color tuning of dithieno[3,2-b:2′,3′-d]arsoles
11. Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy
12. Measurement of glycosphingolipids by means of tandem mass spectrometry and evaluation of them as a biomarker of Fabry disease
13. Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of α-Galactosidase A Protein Levels in Serum and Plasma
14. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts
15. Fabry disease: Biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution
16. Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
17. Efficient Uptake of Recombinant α-Galactosidase A Produced with a Gene-Manipulated Yeast by Fabry Mice Kidneys
18. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis
19. Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease
20. Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease
21. Molecular interaction of imino sugars with human α-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease
22. Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid α-glucosidase (alglucosidase alfa): Insight into the complex formation mechanism
23. Uptake of a Recombinant Human .ALPHA.-L-Iduronidase (laronidase) by Cultured Fibroblasts and Osteoblasts
24. Glycosphingolipid Antigens in Neural Tumor Cell Lines and Anti-Glycosphingolipid Antibodies in Sera of Patients with Neural Tumors
25. Establishment of immortalized Schwann cells from Fabry mice and their low uptake of recombinant α-galactosidase
26. Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta
27. Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease
28. Corrective effect on Fabry mice of yeast recombinant human α-galactosidase with N-linked sugar chains suitable for lysosomal delivery
29. Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice
30. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells
31. Carbohydrate-Carbohydrate Binding of Ganglioside to Integrin α5 Modulates α5β1Function
32. Differential Distribution of Glycosphingolipid Antigens in the Central Nervous System.
33. An immunocytochemical technique with monoclonal antibodies to glycosphingolipids in rat primary cerebellar cultures: influence of detergent permeabilization
34. Changes in Composition of Newly Synthesized Sphingolipids of HeLa Cells During the Cell Cycle. Suppression of Sphingomyelin and Higher-Glycosphingolipid Synthesis and Accumulation of Ceramide and Glucosylceramide in Mitotic Cells
35. Cell-type specific expression of gangliosides in the central nervous system
36. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies
37. DEVELOPMENT OF A MULTI-SURVEYING SYSTEM USING GPS FOR THE MEASUREMENT OF GROUND DISPLACEMENTS
38. Acceptor Substrate Specificity of a Cloned GD3 Synthase that Catalyzes the Biosynthesis of Both GD3 and GD1c/GT1a/GQ1b
39. CRITICAL STRAIN OF NON-HOMOGENEOUS ROCK MASSES
40. A NEW ADJUSTMENT METHOD OF A FREE NET FOR THE GPS SURVEY
41. SELECTION OF OPTIMAL PERIODS OF TIME FOR GPS SURVEYING BASED ON A SKY-PHOTOGRAPH TAKEN WITH A FISH-EYE LENS
42. A COORDINATE TRANSFORMATION FROM SURVEYING TO ORDINARY SURVEYING SYSTEM
43. Expression of De-N-acetyl-gangliosides in Human Melanoma Cells Is Induced by Genistein or Nocodazole
44. Polysialogangliosides Expressed by Amelanotic Melanoma: A Possible Explanation for the Poor Response to Anti‐monosialoganglioside Antibody 202 in a Patient with Melanoma
45. Expression of Sialylparagloboside in a Case of Liposarcoma: Aberrant Glycosylation in Tumors Arising in Adipose Tissues
46. BACK ANALYSIS OF THE NON-ELASTIC DEFORMATIONAL BEHAVIOR OF GROUND MATERIALS
47. DEVELOPMENT OF A GPS-BASED MARKING-POINT SURVEYING SYSTEM
48. Generation of monoclonal antibodies specific for ganglioside lactones: Evidence of the expression of lactone on human melanoma cells
49. CRITICAL SHEAR STRAIN FOR ASSESSING THE STABILITY OF TUNNELS
50. In vitro synthesis of disialoganglioside (Gd1alpha) from asialo-Gm1 using sialyltransferases in rat liver Golgi vesicles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.